Intellia Therapeutics Inc. (NTLA) is one of the largest holdings in the iShares Russell 2000 exchange-traded fund (IWM) and one Real Money subscriber wonders if this stock can help the IWM break out of its long, sideways trading range. The company is a pioneer in the development of CRISPR/Cas9 genome editing.
More from Investing
The safe route is to buy shares, collect the generous dividends and reap the rewards when valuations revert back to normal.
These recently downgraded names are displaying both quantitative and technical deterioration.
LCID's market cap has been deflated, so is it now a bargain, or can it slip further?
The most powerful thing an investor can do is embrace the idea that they don't know what the future holds.